Hangzhou Xian Shi Biotechnology Co.
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- Undisclosed
Investors
- 1
About Hangzhou Xian Shi Biotechnology Co.
, Ltd. is a high-tech company focusing on biomaterials and regenerative medicine industry, and develops next-generation tissue regeneration materials with Zhejiang University, Shanghai Jiao Tong University and many other key laboratories at provincial and ministerial level. The company's core team consists of scientists, doctors and engineers from the fields of biomaterials and regenerative medicine, and has won awards such as the Innovation Award in the 2021-SATOL (China) Life Science and Technology Innovation and Entrepreneurship Competition. The company has its own four major technology platforms including decellularization technology platform, hydrogel microsphere platform, electrostatic spinning nanofiber platform and bionic mineralization platform, the platforms are used to developed a variety of tissue regeneration material products, such as endometrial repair materials, breast reconstruction filling materials, etc. In 2023, the company's first endometrial repair product, a highly adherent decellularized matrix microfiber material, completed registration for clinical trials.
Who invested in Hangzhou Xian Shi Biotechnology Co.
1 investor across 1 round
See all investors in Hangzhou Xian Shi Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 26, 2023
Amount
Undisclosed
Investors
Questions about Hangzhou Xian Shi Biotechnology Co.
Who invested in Hangzhou Xian Shi Biotechnology Co.?
Hangzhou Xian Shi Biotechnology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Xian Shi Biotechnology Co. raised?
Hangzhou Xian Shi Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou Xian Shi Biotechnology Co. last raise money?
Hangzhou Xian Shi Biotechnology Co.'s most recent round on record is a Series A, in Jun 2023.
What does Hangzhou Xian Shi Biotechnology Co. do?
Hangzhou Xian Shi Biotechnology Co. is a healthcare company.
Where is Hangzhou Xian Shi Biotechnology Co. headquartered?
Hangzhou Xian Shi Biotechnology Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Xian Shi Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Hangzhou Xian Shi Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Hangzhou Xian Shi Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.